A rare synchrony of adenocarcinoma of the ampulla with an ileal gastrointestinal stromal tumor: A case report

Table 4 Management of Localized gastrointestinal stromal tumors

Imatinib-sensitive mutation					Imatinib-insensitive mutation
Uncomplicated (No major complications expected with surgery)		Complicated (Major complications expected with surgery)			See Table 5
Surgery (Resection of tumor with negative margins)		Preoperative imatinib for 6 mo
Low/Intermediaterisk	High risk	Tumor negative or microscopically positive margins feasible		Tumor negative or microscopically positive margins not feasible
Follow-up	Adjuvant treatment with imatinib for 36 mo	Low/Intermediaterisk	High risk	Manage as advanced GIST or metastatic GIST
		Follow-up	Adjuvant imatinib for 36 mo

GIST: Gastrointestinal stromal tumors.